University of Aberdeen logo

AURA - Aberdeen University Research Archive

 

Proton pump inhibitor and histamine-2 receptor antagonist use and risk of liver cancer in two population-based studies

Simple item page
dc.contributor.authorTran, Kim Tu
dc.contributor.authorMcMenamin, Úna C.
dc.contributor.authorHicks, Blánaid
dc.contributor.authorMurchie, Peter
dc.contributor.authorThrift, Aaron P.
dc.contributor.authorColeman, Helen G.
dc.contributor.authorIversen, Lisa
dc.contributor.authorJohnston, Brian T.
dc.contributor.authorLee, Amanda J.
dc.contributor.authorCardwell, Chris R.
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Grampian Data Safe Haven (DaSH)en
dc.contributor.institutionUniversity of Aberdeen.Institute of Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Medical Statisticsen
dc.date.accessioned2019-05-08T23:02:11Z
dc.date.available2019-05-08T23:02:11Z
dc.date.embargoedUntil2019-05-09
dc.date.issued2018-07
dc.descriptionThe analysis of UK Biobank has been conducted using the UK Biobank Resource under Application Number 34374. We acknowledge collaboration with the Research Applications and Data Management Team lead by Ms Katie Wilde, University of Aberdeen in conducting this study. KTT is supported by the Vietnam International Education Cooperation Department. Access to PCCIU data was provided by Queen’s University Belfast and the Centre for Academic Primary Care, University of Aberdeen. Access to the UK Biobank was funded by a Cancer Research UK Population Research Postdoctoral Fellowship awarded to ÚCMcM. HGC is a co-investigator of the UKCRC Centre of Excellence for Public Health Northern Ireland.en
dc.description.statusPeer revieweden
dc.format.extent10
dc.format.extent760008
dc.identifier118877471
dc.identifierd68a80e6-f04f-45c0-9f4a-2332febe8e92
dc.identifier85047418442
dc.identifier.citationTran, K T, McMenamin, Ú C, Hicks, B, Murchie, P, Thrift, A P, Coleman, H G, Iversen, L, Johnston, B T, Lee, A J & Cardwell, C R 2018, 'Proton pump inhibitor and histamine-2 receptor antagonist use and risk of liver cancer in two population-based studies', Alimentary Pharmacology & Therapeutics, vol. 48, no. 1, pp. 55-64. https://doi.org/10.1111/apt.14796en
dc.identifier.doi10.1111/apt.14796
dc.identifier.iss1en
dc.identifier.issn0269-2813
dc.identifier.otherORCID: /0000-0001-9968-5991/work/83704281
dc.identifier.otherORCID: /0000-0002-4865-9061/work/159078228
dc.identifier.urihttp://hdl.handle.net/2164/12243
dc.identifier.vol48en
dc.language.isoeng
dc.relation.ispartofAlimentary Pharmacology & Therapeuticsen
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subjectRC0254 Neoplasms. Tumors. Oncology (including Cancer)en
dc.subjectCancer Research UKen
dc.subject.lccRC0254en
dc.titleProton pump inhibitor and histamine-2 receptor antagonist use and risk of liver cancer in two population-based studiesen
dc.typeJournal articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
PPIs_and_liver_cancer_R1.pdf
Size:
742.2 KB
Format:
Adobe Portable Document Format
Download

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
8.31 KB
Format:
Plain Text
Description:
Download

Collections

All research
Applied Health Sciences research
University Office research